S'pore Immunology Network, Galderma Labs to collaborate on acne study - Channel News Asia

Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!

SINGAPORE: A*STAR's Singapore Immunology Network (SIgN) and Swiss pharmaceutical company, Galderma Laboratories, have signed an agreement to study how acne develops in the skin.

A joint statement said understanding the immune mechanisms that contribute to the development of the inflammatory phase of acne will help scientists treat the condition at its roots.

The research may lead to new treatments for acne, which has a global market estimated to be worth US$3 billion.

The project will be supported by several research groups at SIgN over the next two years.


18 Oct, 2011

Source: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGrwMk57qVwyLn9Wk1zShiMGTcfrQ&url=http://www.channelnewsasia.com/stories/singaporelocalnews/view/1160173/1/.html
Manage subscription | Powered by rssforward.com

What's on Your Mind...

Powered by Blogger.